{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T18:22:21Z","timestamp":1759602141528},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Syst Biol"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Epidermal growth factor receptor (EGFR) signaling plays an important role in the regulation of cell proliferation, survival, metastasis, and invasion in various tumors. Earlier studies showed that the EGFR is frequently overexpressed in non-small-cell lung cancer (NSCLC) and EGFR mutations at specific amino acid residues in the kinase domain induce altered responsiveness to gefitinib, a small molecule EGFR tyrosine kinase inhibitor. However, the mechanism underlying the drug response modulated by EGFR mutation is still largely unknown. To elucidate drug response in EGFR signal transduction pathway in which complex dynamics of multiple molecules involved, a systematic approach is necessary. In this paper, we performed experimental and computational analyses to clarify the underlying mechanism of EGFR signaling and cell-specific gefitinib responsiveness in three H1299-derived NSCLC cell lines; H1299 wild type (H1299WT), H1299 with an overexpressed wild type EGFR (H1299EGFR-WT), and H1299 with an overexpressed mutant EGFR L858R (H1299L858R; gefitinib sensitive mutant).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>We predicted and experimentally verified that Mig6, which is a known negative regulator of EGFR and specifically expressed in H1299L858R cells, synergized with gefitinib to suppress cellular growth. Computational analyses indicated that this inhibitory effect is amplified at the phosphorylation\/dephosphorylation steps of MEK and ERK.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Thus, we showed that L858R receptor mutation in combination with expression of its negative regulator, Mig6, alters signaling outcomes and results in variable drug sensitivity.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1752-0509-5-29","type":"journal-article","created":{"date-parts":[[2011,2,18]],"date-time":"2011-02-18T19:32:29Z","timestamp":1298057549000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Epidermal growth factor receptor mutation in combination with expression of MIG6 alters gefitinib sensitivity"],"prefix":"10.1186","volume":"5","author":[{"given":"Yoshimi","family":"Naruo","sequence":"first","affiliation":[]},{"given":"Takeshi","family":"Nagashima","sequence":"additional","affiliation":[]},{"given":"Ryoko","family":"Ushikoshi-Nakayama","sequence":"additional","affiliation":[]},{"given":"Yuko","family":"Saeki","sequence":"additional","affiliation":[]},{"given":"Takashi","family":"Nakakuki","sequence":"additional","affiliation":[]},{"given":"Takashi","family":"Naka","sequence":"additional","affiliation":[]},{"given":"Hiroshi","family":"Tanaka","sequence":"additional","affiliation":[]},{"given":"Shih-Feng","family":"Tsai","sequence":"additional","affiliation":[]},{"given":"Mariko","family":"Okada-Hatakeyama","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2011,2,18]]},"reference":[{"key":"621_CR1","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.1093\/emboj\/19.13.3159","volume":"19","author":"MA Olayioye","year":"2000","unstructured":"Olayioye MA, Neve RM, Lane HA, Hynes NE: The ErbB signaling network: receptor heterodimerization in development and cancer. EMBO J 2000, 19: 3159-67. 10.1093\/emboj\/19.13.3159","journal-title":"EMBO J"},{"key":"621_CR2","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/35052073","volume":"2","author":"Y Yarden","year":"2001","unstructured":"Yarden Y, Sliwkowski MX: Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2001, 2: 127-37. 10.1038\/35052073","journal-title":"Nat Rev Mol Cell Biol"},{"key":"621_CR3","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nrc1609","volume":"5","author":"NE Hynes","year":"2005","unstructured":"Hynes NE, Lane HA: ERBB receptors and cancer: the complexity of targeted inhibitors. Nat Rev Cancer 2005, 5: 341-54. 10.1038\/nrc1609","journal-title":"Nat Rev Cancer"},{"key":"621_CR4","doi-asserted-by":"publisher","first-page":"5268","DOI":"10.1158\/1078-0432.CCR-05-1554","volume":"12","author":"M Scaltriti","year":"2006","unstructured":"Scaltriti M, Baselga J: The epidermal growth factor receptor pathway: a model for targeted therapy. Clin Cancer Res 2006, 12: 5268-72. 10.1158\/1078-0432.CCR-05-1554","journal-title":"Clin Cancer Res"},{"key":"621_CR5","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1023\/A:1008209720526","volume":"8","author":"BR Voldborg","year":"1997","unstructured":"Voldborg BR, Damstrup L, Spang-Thomsen M, Poulsen HS: Epidermal growth factor receptor (EGFR) and EGFR mutations, function and possible role in clinical trials. Ann Oncol 1997, 8: 1197-206. 10.1023\/A:1008209720526","journal-title":"Ann Oncol"},{"key":"621_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0014-4827(02)00098-8","volume":"284","author":"RN Jorissen","year":"2003","unstructured":"Jorissen RN, Walker F, Pouliot N, Garrett TP, Ward CW, Burgess AW: Epidermal growth factor receptor: mechanisms of activation and signalling. Exp Cell Res 2003, 284: 31-53. 10.1016\/S0014-4827(02)00098-8","journal-title":"Exp Cell Res"},{"key":"621_CR7","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1016\/j.cellsig.2007.06.023","volume":"19","author":"R Zandi","year":"2007","unstructured":"Zandi R, Larsen AB, Andersen P, Stockhausen MT, Poulsen HS: Mechanisms for oncogenic activation of the epidermal growth factor receptor. Cell Signal 2007, 19: 2013-23. 10.1016\/j.cellsig.2007.06.023","journal-title":"Cell Signal"},{"key":"621_CR8","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/0092-8674(95)90401-8","volume":"80","author":"CJ Marshall","year":"1995","unstructured":"Marshall CJ: Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 1995, 80: 179-185. 10.1016\/0092-8674(95)90401-8","journal-title":"Cell"},{"key":"621_CR9","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1016\/S0959-8049(01)00231-3","volume":"37","author":"RI Nicholson","year":"2001","unstructured":"Nicholson RI, Gee JM, Harper ME: EGFR and cancer prognosis. Eur J Cancer 2001, 37: S9-15. 10.1016\/S0959-8049(01)00231-3","journal-title":"Eur J Cancer"},{"key":"621_CR10","doi-asserted-by":"publisher","first-page":"3798","DOI":"10.1200\/JCO.2003.11.069","volume":"21","author":"FR Hirsch","year":"2003","unstructured":"Hirsch FR, Varella-Garcia M, Bunn PA Jr, Di Maria MV, Veve R, Bremmes RM, Bar\u00f3n AE, Zeng C, Franklin WA: Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis. J Clin Oncol 2003, 21: 3798-3807. 10.1200\/JCO.2003.11.069","journal-title":"J Clin Oncol"},{"key":"621_CR11","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/S0092-8674(00)81612-8","volume":"95","author":"PW Sternberg","year":"1998","unstructured":"Sternberg PW, Alberola-Ila J: Conspiracy theory: RAS and RAF do not act alone. Cell 1998, 95: 447-50. 10.1016\/S0092-8674(00)81612-8","journal-title":"Cell"},{"key":"621_CR12","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1016\/j.cellsig.2006.05.015","volume":"18","author":"ES Henson","year":"2006","unstructured":"Henson ES, Gibson SB: Surviving cell death through epidermal growth factor (EGF) signal transduction pathways: implications for cancer therapy. Cell Signal 2006, 18: 2089-97. 10.1016\/j.cellsig.2006.05.015","journal-title":"Cell Signal"},{"issue":"2","key":"621_CR13","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/ijc.21496","volume":"118","author":"H Shigematsu","year":"2006","unstructured":"Shigematsu H, Gazdar AF: Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers. Int. J. Cancer 2006,118(2):257-62. 10.1002\/ijc.21496","journal-title":"Int. J. Cancer"},{"key":"621_CR14","doi-asserted-by":"publisher","first-page":"13306","DOI":"10.1073\/pnas.0405220101","volume":"101","author":"W Pao","year":"2004","unstructured":"Pao W, Miller V, Zakowski M, Doherty J, Politi K, Sarkaria I, Singh B, Heelan R, Rusch V, Fulton L, Mardis E, Kupfer D, Wilson R, Kris M, Varmus H: EGF receptor gene mutations are common in lung cancers from \"never smokers\" and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc Natl Acad Sci USA 2004, 101: 13306-11. 10.1073\/pnas.0405220101","journal-title":"Proc Natl Acad Sci USA"},{"key":"621_CR15","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/sj.onc.1209159","volume":"25","author":"YR Chen","year":"2006","unstructured":"Chen YR, Fu YN, Lin CH, Yang ST, Hu SF, Chen YT, Tsai SF, Huang SF: Distinctive activation patterns in constitutively active and gefitinib-sensitive EGFR mutants. Oncogene 2006, 25: 1205-15. 10.1038\/sj.onc.1209159","journal-title":"Oncogene"},{"key":"621_CR16","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.ccr.2006.12.017","volume":"11","author":"CH Yun","year":"2007","unstructured":"Yun CH, Boggon TJ, Li Y, Woo MS, Greulich H, Meyerson M, Eck MJ: Structures of lung cancer-derived EGFR mutants and inhibitor complexes: mechanism of activation and insights into differential inhibitor sensitivity. Cancer Cell 2007, 11: 217-27. 10.1016\/j.ccr.2006.12.017","journal-title":"Cancer Cell"},{"key":"621_CR17","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nbt1068","volume":"23","author":"MA Fabian","year":"2005","unstructured":"Fabian MA, Biggs WH, Treiber DK, Atteridge CE, Azimioara MD, Benedetti MG, Carter TA, Ciceri P, Edeen PT, Floyd M, Ford JM, Galvin M, Gerlach JL, Grotzfeld RM, Herrgard S, Insko DE, Insko MA, Lai AG, L\u00e9lias JM, Mehta SA, Milanov ZV, Velasco AM, Wodicka LM, Patel HK, Zarrinkar PP, Lockhart DJ: A small molecule-kinase interaction map for clinical kinase inhibitors. Nat Biotechnol 2005, 23: 329-36. 10.1038\/nbt1068","journal-title":"Nat Biotechnol"},{"key":"621_CR18","doi-asserted-by":"publisher","first-page":"5239","DOI":"10.1111\/j.1742-4658.2009.07220.x","volume":"276","author":"T Nagashima","year":"2009","unstructured":"Nagashima T, Ushikoshi-Nakayama R, Suenaga A, Ide K, Yumoto N, Naruo Y, Takahashi K, Saeki Y, Taiji M, Tanaka H, Tsai SF, Hatakeyama M: Mutation of epidermal growth factor receptor is associated with MIG6 expression. FEBS J 2009, 276: 5239-51. 10.1111\/j.1742-4658.2009.07220.x","journal-title":"FEBS J"},{"key":"621_CR19","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/nature05998","volume":"450","author":"X Zhang","year":"2007","unstructured":"Zhang X, Pickin KA, Bose R, Jura N, Cole PA, Kuriyan J: Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface. Nature 2007, 450: 741-4. 10.1038\/nature05998","journal-title":"Nature"},{"key":"621_CR20","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/nm1401","volume":"12","author":"I Ferby","year":"2006","unstructured":"Ferby I, Reschke M, Kudlacek O, Knyazev P, Pant\u00e8 G, Amann K, Sommergruber W, Kraut N, Ullrich A, F\u00e4ssler R, Klein R: Mig6 is a negative regulator of EGF receptor-mediated skin morphogenesis and tumor formation. Nat Med 2006, 12: 568-73. 10.1038\/nm1401","journal-title":"Nat Med"},{"key":"621_CR21","doi-asserted-by":"publisher","first-page":"7833","DOI":"10.1038\/sj.onc.1210590","volume":"26","author":"S Anastasi","year":"2007","unstructured":"Anastasi S, Baietti MF, Frosi Y, Alem\u00e0 S, Segatto O: The evolutionarily conserved EBR module of RALT\/MIG6 mediates suppression of the EGFR catalytic activity. Oncogene 2007, 26: 7833-46. 10.1038\/sj.onc.1210590","journal-title":"Oncogene"},{"key":"621_CR22","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/sj.onc.1209790","volume":"26","author":"YW Zhang","year":"2007","unstructured":"Zhang YW, Staal B, Su Y, Swiatek P, Zhao P, Cao B, Resau J, Sigler R, Bronson R, Vande Woude GF: Evidence that MIG-6 is a tumor-suppressor gene. Oncogene 2007, 26: 269-76. 10.1038\/sj.onc.1209790","journal-title":"Oncogene"},{"key":"621_CR23","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1158\/0008-5472.CAN-03-2361","volume":"64","author":"S Amatschek","year":"2004","unstructured":"Amatschek S, Koenig U, Auer H, Steinlein P, Pacher M, Gruenfelder A, Dekan G, Vogl S, Kubista E, Heider KH, Stratowa C, Schreiber M, Sommergruber W: Tissue-wide expression profiling using cDNA subtraction and microarrays to identify tumor-specific genes. Cancer Res 2004, 64: 844-56. 10.1158\/0008-5472.CAN-03-2361","journal-title":"Cancer Res"},{"key":"621_CR24","doi-asserted-by":"publisher","first-page":"4540","DOI":"10.1038\/sj.onc.1208658","volume":"24","author":"S Anastasi","year":"2005","unstructured":"Anastasi S, Sala G, Huiping C, Caprini E, Russo G, Iacovelli S, Lucini F, Ingvarsson S, Segatto O: Loss of RALT\/MIG-6 expression in ERBB2-amplified breast carcinomas enhances ErbB-2 oncogenic potency and favors resistance to Herceptin. Oncogene 2005, 24: 4540-8. 10.1038\/sj.onc.1208658","journal-title":"Oncogene"},{"key":"621_CR25","doi-asserted-by":"publisher","first-page":"30169","DOI":"10.1074\/jbc.274.42.30169","volume":"274","author":"BN Kholodenko","year":"1999","unstructured":"Kholodenko BN, Demin OV, Moehren G, Hoek JB: Quantification of short term signaling by the epidermal growth factor receptor. J Biol Chem 1999, 274: 30169-81. 10.1074\/jbc.274.42.30169","journal-title":"J Biol Chem"},{"key":"621_CR26","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0014-5793(00)02037-8","volume":"482","author":"FA Brightman","year":"2000","unstructured":"Brightman FA, Fell DA: Differential feedback regulation of the MAPK cascade underlies the quantitative differences in EGF and NGF signalling in PC12 cells. FEBS Lett 2000, 482: 169-74. 10.1016\/S0014-5793(00)02037-8","journal-title":"FEBS Lett"},{"key":"621_CR27","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/nbt0402-370","volume":"20","author":"B Schoeberl","year":"2002","unstructured":"Schoeberl B, Eichler-Jonsson C, Gilles ED, M\u00fcller G: Computational modeling of the dynamics of the MAP kinase cascade activated by surface and internalized EGF receptors. Nat Biotechnol 2002, 20: 370-5. 10.1038\/nbt0402-370","journal-title":"Nat Biotechnol"},{"key":"621_CR28","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1042\/bj20021824","volume":"373","author":"M Hatakeyama","year":"2003","unstructured":"Hatakeyama M, Kimura S, Naka T, Kawasaki T, Yumoto N, Ichikawa M, Kim JH, Saito K, Saeki M, Shirouzu M, Yokoyama S, Konagaya A: A computational model on the modulation of mitogen-activated protein kinase (MAPK) and Akt pathways in heregulin-induced ErbB signalling. Biochem J 2003, 373: 451-63. 10.1042\/BJ20021824","journal-title":"Biochem J"},{"key":"621_CR29","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0962-8924(02)00009-0","volume":"13","author":"HS Wiley","year":"2003","unstructured":"Wiley HS, Shvartsman SY, Lauffenburger DA: Computational modeling of the EGF-receptor system: a paradigm for systems biology. Trends Cell Biol 2003, 13: 43-50. 10.1016\/S0962-8924(02)00009-0","journal-title":"Trends Cell Biol"},{"key":"621_CR30","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/j.bbrc.2004.01.009","volume":"314","author":"S Yamada","year":"2004","unstructured":"Yamada S, Taketomi T, Yoshimura A: Model analysis of difference between EGF pathway and FGF pathway. Biochem Biophys Res Commun 2004, 314: 1113-1120. 10.1016\/j.bbrc.2004.01.009","journal-title":"Biochem Biophys Res Commun"},{"key":"621_CR31","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/ncb1233","volume":"7","author":"S Sasagawa","year":"2005","unstructured":"Sasagawa S, Ozaki Y, Fujita K, Kuroda S: Prediction and validation of the distinct dynamics of transient and sustained ERK activation. Nat Cell Biol 2005, 7: 365-73. 10.1038\/ncb1233","journal-title":"Nat Cell Biol"},{"key":"621_CR32","doi-asserted-by":"publisher","first-page":"19925","DOI":"10.1074\/jbc.M600482200","volume":"281","author":"A Kiyatkin","year":"2006","unstructured":"Kiyatkin A, Aksamitiene E, Markevich NI, Borisov NM, Hoek JB, Kholodenko BN: Scaffolding protein Grb2-associated binder 1 sustains epidermal growth factor-induced mitogenic and survival signaling by multiple positive feedback loops. J Biol Chem 2006, 281: 19925-38. 10.1074\/jbc.M600482200","journal-title":"J Biol Chem"},{"key":"621_CR33","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/msb4100188","volume":"3","author":"MR Birtwistle","year":"2007","unstructured":"Birtwistle MR, Hatakeyama M, Yumoto N, Ogunnaike BA, Hoek JB, Kholodenko BN: Ligand-dependent responses of the ErbB signaling network: experimental and modeling analyses. Mol Syst Biol 2007, 3: 144. 10.1038\/msb4100188","journal-title":"Mol Syst Biol"},{"key":"621_CR34","doi-asserted-by":"publisher","first-page":"5505","DOI":"10.1111\/j.1742-4658.2007.06066.x","volume":"274","author":"J Wolf","year":"2007","unstructured":"Wolf J, Dronov S, Tobin F, Goryanin I: The impact of the regulatory design on the response of epidermal growth factor receptor-mediated signal transduction towards oncogenic mutations. FEBS J 2007, 274: 5505-17. 10.1111\/j.1742-4658.2007.06066.x","journal-title":"FEBS J"},{"key":"621_CR35","doi-asserted-by":"publisher","first-page":"e1782","DOI":"10.1371\/journal.pone.0001782","volume":"3","author":"T Nakakuki","year":"2008","unstructured":"Nakakuki T, Yumoto N, Naka T, Shirouzu M, Yokoyama S, Hatakeyama M: Topological analysis of MAPK cascade for kinetic ErbB signaling. PLoS ONE 2008, 3: e1782. 10.1371\/journal.pone.0001782","journal-title":"PLoS ONE"},{"key":"621_CR36","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1016\/j.febslet.2008.05.026","volume":"582","author":"CY Ung","year":"2008","unstructured":"Ung CY, Li H, Ma XH, Jia J, Li BW, Low BC, Chen YZ: Simulation of the regulation of EGFR endocytosis and EGFR-ERK signaling by endophilin-mediated RhoA-EGFR crosstalk. FEBS Lett 2008, 582: 2283-90. 10.1016\/j.febslet.2008.05.026","journal-title":"FEBS Lett"},{"key":"621_CR37","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1093\/bioinformatics\/btn635","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Ung CY, Ma XH, Li BW, Low BC, Cao ZW, Chen YZ: Simulation of crosstalk between small GTPase RhoA and EGFR-ERK signaling pathway via MEKK1. Bioinformatics 2009, 25: 358-64. 10.1093\/bioinformatics\/btn635","journal-title":"Bioinformatics"},{"key":"621_CR38","first-page":"335","volume-title":"Proc of the 2003 Int Conf on Systems, Man, and Cybernetics","author":"S Kimura","year":"2003","unstructured":"Kimura S, Konagaya A: High dimensional function optimization using a new genetic local search suitable for parallel computers. Proc of the 2003 Int Conf on Systems, Man, and Cybernetics 2003, 335-342."},{"key":"621_CR39","doi-asserted-by":"publisher","first-page":"R49","DOI":"10.1186\/gb-2004-5-7-r49","volume":"5","author":"JL Hartman","year":"2004","unstructured":"Hartman JL, Tippery NP: Systematic quantification of gene interactions by phenotypic array analysis. Genome Biol 2004, 5: R49. 10.1186\/gb-2004-5-7-r49","journal-title":"Genome Biol"},{"key":"621_CR40","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/nrd1609","volume":"4","author":"CT Keith","year":"2005","unstructured":"Keith CT, Borisy AA, Stockwell BR: Multicomponent therapeutics for networked systems. Nat Rev Drug Disco 2005, 4: 71-8. 10.1038\/nrd1609","journal-title":"Nat Rev Drug Disco"},{"key":"621_CR41","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1093\/emboj\/16.2.281","volume":"16","author":"MA Lemmon","year":"1997","unstructured":"Lemmon MA, Bu Z, Ladbury JE, Zhou M, Pinchasi D, Lax I, Engelman DM, Schlessinger J: Two EGF molecules contribute additively to stabilization of the EGFR dimer. EMBO J 1997, 16: 281-94. 10.1093\/emboj\/16.2.281","journal-title":"EMBO J"},{"key":"621_CR42","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/0968-0004(88)90219-8","volume":"13","author":"J Schlessinger","year":"1988","unstructured":"Schlessinger J: Signal transduction by allosteric receptor oligomerization. Trends Biochem Sci 1988, 13: 443-7. 10.1016\/0968-0004(88)90219-8","journal-title":"Trends Biochem Sci"},{"key":"621_CR43","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/S0092-8674(02)00966-2","volume":"110","author":"J Schlessinger","year":"2002","unstructured":"Schlessinger J: Ligand-induced, receptor-mediated dimerization and activation of EGF receptor. Cell 2002, 110: 669-72. 10.1016\/S0092-8674(02)00966-2","journal-title":"Cell"},{"key":"621_CR44","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1042\/bj2840569","volume":"284","author":"N Hashimoto","year":"1992","unstructured":"Hashimoto N, Zhang WR, Goldstein BJ: Insulin receptor and epidermal growth factor receptor dephosphorylation by three major rat liver protein-tyrosine phosphatases expressed in a recombinant bacterial system. Biochem J 1992, 284: 569-76.","journal-title":"Biochem J"},{"key":"621_CR45","doi-asserted-by":"publisher","first-page":"5386","DOI":"10.1074\/jbc.271.10.5386","volume":"271","author":"ZY Zhang","year":"1996","unstructured":"Zhang ZY, Walsh AB, Wu L, McNamara DJ, Dobrusin EM, Miller WT: Determinants of substrate recognition in the protein-tyrosine phosphatase, PTP1. J Biol Chem 1996, 271: 5386-92. 10.1074\/jbc.271.10.5386","journal-title":"J Biol Chem"},{"key":"621_CR46","doi-asserted-by":"publisher","first-page":"3663","DOI":"10.1101\/gad.12.23.3663","volume":"12","author":"G Levkowitz","year":"1998","unstructured":"Levkowitz G, Waterman H, Zamir E, Kam Z, Oved S, Langdon WY, Beguinot L, Geiger B, Yarden Y: c-Cbl\/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor. Genes Dev 1998, 12: 3663-74. 10.1101\/gad.12.23.3663","journal-title":"Genes Dev"},{"key":"621_CR47","doi-asserted-by":"publisher","first-page":"6845","DOI":"10.1128\/MCB.19.10.6845","volume":"19","author":"SK Muthuswamy","year":"1999","unstructured":"Muthuswamy SK, Gilman M, Brugge JS: Controlled dimerization of ErbB receptors provides evidence for differential signaling by homo- and heterodimers. Mol Cell Biol 1999, 19: 6845-57.","journal-title":"Mol Cell Biol"},{"key":"621_CR48","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/0092-8674(93)90146-H","volume":"73","author":"L Buday","year":"1993","unstructured":"Buday L, Downward J: Epidermal growth factor regulates p21ras through the formation of a complex of receptor, Grb2 adapter protein, and Sos nucleotide exchange factor. Cell 1993, 73: 611-20. 10.1016\/0092-8674(93)90146-H","journal-title":"Cell"},{"key":"621_CR49","doi-asserted-by":"publisher","first-page":"4403","DOI":"10.1128\/MCB.15.8.4403","volume":"15","author":"AG Batzer","year":"1995","unstructured":"Batzer AG, Blaikie P, Nelson K, Schlessinger J, Margolis B: The phosphotyrosine interaction domain of Shc binds an LXNPXY motif on the epidermal growth factor receptor. Mol Cell Biol 1995, 15: 4403-9.","journal-title":"Mol Cell Biol"},{"key":"621_CR50","doi-asserted-by":"publisher","first-page":"6322","DOI":"10.1038\/sj.onc.1204776","volume":"20","author":"KS Ravichandran","year":"2001","unstructured":"Ravichandran KS: Signaling via Shc family adapter proteins. Oncogene 2001, 20: 6322-30. 10.1038\/sj.onc.1204776","journal-title":"Oncogene"},{"key":"621_CR51","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1681\/ASN.V561288","volume":"5","author":"B Margolis","year":"1994","unstructured":"Margolis B, Skolnik EY: Activation of Ras by receptor tyrosine kinases. J Am Soc Nephrol 1994, 5: 1288-99.","journal-title":"J Am Soc Nephrol"},{"key":"621_CR52","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/28548","volume":"394","author":"PA Boriack-Sjodin","year":"1998","unstructured":"Boriack-Sjodin PA, Margarit SM, Bar-Sagi D, Kuriyan J: The structural basis of the activation of Ras by Sos. Nature 1998, 394: 337-43. 10.1038\/28548","journal-title":"Nature"},{"key":"621_CR53","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1128\/MCB.11.5.2511","volume":"11","author":"XQ Liu","year":"1991","unstructured":"Liu XQ, Pawson T: The epidermal growth factor receptor phosphorylates GTPase-activating protein (GAP) at Tyr-460, adjacent to the GAP SH2 domains. Mol Cell Biol 1991, 11: 2511-6.","journal-title":"Mol Cell Biol"},{"key":"621_CR54","first-page":"123","volume":"7","author":"Z Wang","year":"1996","unstructured":"Wang Z, Tung PS, Moran MF: Association of p120 ras GAP with endocytic components and colocalization with epidermal growth factor (EGF) receptor in response to EGF stimulation. Cell Growth Differ 1996, 7: 123-33.","journal-title":"Cell Growth Differ"},{"key":"621_CR55","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.tcb.2004.05.003","volume":"14","author":"A Bernards","year":"2004","unstructured":"Bernards A, Settleman J: GAP control: regulating the regulators of small GTPases. Trends Cell Biol 2004, 14: 377-85. 10.1016\/j.tcb.2004.05.003","journal-title":"Trends Cell Biol"},{"key":"621_CR56","doi-asserted-by":"publisher","first-page":"8683","DOI":"10.1073\/pnas.90.18.8683","volume":"90","author":"H Koide","year":"1993","unstructured":"Koide H, Satoh T, Nakafuku M, Kaziro Y: GTP-dependent association of Raf-1 with Ha-Ras: identification of Raf as a target downstream of Ras in mammalian cells. Proc Natl Acad Sci USA 1993, 90: 8683-6. 10.1073\/pnas.90.18.8683","journal-title":"Proc Natl Acad Sci USA"},{"key":"621_CR57","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/S0898-6568(02)00139-0","volume":"5","author":"H Chong","year":"2003","unstructured":"Chong H, Vikis HG, Guan KL: Mechanisms of regulating the Raf kinase family. Cell Signal 2003, 5: 463-9. 10.1016\/S0898-6568(02)00139-0","journal-title":"Cell Signal"},{"key":"621_CR58","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1042\/bj3510289","volume":"351","author":"W Kolch","year":"2000","unstructured":"Kolch W: Meaningful relationships: the regulation of the Ras\/Raf\/MEK\/ERK pathway by protein interactions. Biochem J 2000, 351: 289-305. 10.1042\/0264-6021:3510289","journal-title":"Biochem J"},{"key":"621_CR59","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1210\/er.22.2.153","volume":"22","author":"G Pearson","year":"2001","unstructured":"Pearson G, Robinson F, Beers Gibson T, Xu BE, Karandikar M, Berman K, Cobb MH: Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 2001, 22: 153-83. 10.1210\/er.22.2.153","journal-title":"Endocr Rev"},{"key":"621_CR60","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/S0955-0674(99)00075-7","volume":"12","author":"SM Keyse","year":"2000","unstructured":"Keyse SM: Protein phosphatases and the regulation of mitogen-activated protein kinase signalling. Curr Opin Cell Biol 2000, 12: 186-92. 10.1016\/S0955-0674(99)00075-7","journal-title":"Curr Opin Cell Biol"},{"key":"621_CR61","doi-asserted-by":"publisher","first-page":"31818","DOI":"10.1074\/jbc.M203969200","volume":"277","author":"B Zhou","year":"2002","unstructured":"Zhou B, Wang ZX, Zhao Y, Brautigan DL, Zhang ZY: The specificity of extracellular signal-regulated kinase 2 dephosphorylation by protein phosphatases. J Biol Chem 2002, 277: 31818-25. 10.1074\/jbc.M203969200","journal-title":"J Biol Chem"},{"key":"621_CR62","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/0014-5793(94)00480-3","volume":"346","author":"CF Chuang","year":"1994","unstructured":"Chuang CF, Ng SY: Functional divergence of the MAP kinase pathway. ERK1 and ERK2 activate specific transcription factors. FEBS Lett 1994, 346: 229-34. 10.1016\/0014-5793(94)00480-3","journal-title":"FEBS Lett"},{"key":"621_CR63","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/j.1460-2075.1995.tb07076.x","volume":"14","author":"H Gille","year":"1995","unstructured":"Gille H, Kortenjann M, Thomae O, Moomaw C, Slaughter C, Cobb MH, Shaw PE: ERK phosphorylation potentiates Elk-1-mediated ternary complex formation and transactivation. EMBO J 1995, 14: 951-62.","journal-title":"EMBO J"},{"key":"621_CR64","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/sj.onc.1201520","volume":"16","author":"E Kerkhoff","year":"1998","unstructured":"Kerkhoff E, Houben R, L\u00f6ffler S, Troppmair J, Lee JE, Rapp UR: Regulation of c-myc expression by Ras\/Raf signalling. Oncogene 1998, 16: 211-6. 10.1038\/sj.onc.1201520","journal-title":"Oncogene"},{"key":"621_CR65","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1128\/MCB.19.4.2435","volume":"19","author":"HJ Schaeffer","year":"1999","unstructured":"Schaeffer HJ, Weber MJ: Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol Cell Biol 1999, 19: 2435-44.","journal-title":"Mol Cell Biol"},{"key":"621_CR66","doi-asserted-by":"publisher","first-page":"7927","DOI":"10.1073\/pnas.95.14.7927","volume":"95","author":"S Miyake","year":"1998","unstructured":"Miyake S, Lupher ML Jr, Druker B, Band H: The tyrosine kinase regulator Cbl enhances the ubiquitination and degradation of the platelet-derived growth factor receptor alpha. Proc Natl Acad Sci USA 1998, 95: 7927-32. 10.1073\/pnas.95.14.7927","journal-title":"Proc Natl Acad Sci USA"},{"key":"621_CR67","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1677\/erc.1.00600","volume":"11","author":"PM Harari","year":"2004","unstructured":"Harari PM: Epidermal growth factor receptor inhibition strategies in oncology. Endocr Relat Cancer 2004, 11: 689-708. 10.1677\/erc.1.00600","journal-title":"Endocr Relat Cancer"},{"key":"621_CR68","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.gene.2005.10.018","volume":"366","author":"N Normanno","year":"2006","unstructured":"Normanno N, De Luca A, Bianco C, Strizzi L, Mancino M, Maiello MR, Carotenuto A, De Feo G, Caponigro F, Salomon DS: Epidermal growth factor receptor (EGFR) signaling in cancer. Gene 2006, 366: 2-16. 10.1016\/j.gene.2005.10.018","journal-title":"Gene"},{"key":"621_CR69","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1183\/09031936.02.00296502","volume":"20","author":"AP Meert","year":"2002","unstructured":"Meert AP, Martin B, Delmotte P, Berghmans T, Lafitte JJ, Mascaux C, Paesmans M, Steels E, Verdebout JM, Sculier JP: The role of EGF-R expression on patient survival in lung cancer: a systematic review with meta-analysis. Eur Respir J 2002, 20: 975-81. 10.1183\/09031936.02.00296502","journal-title":"Eur Respir J"},{"key":"621_CR70","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1056\/NEJMoa040938","volume":"350","author":"TJ Lynch","year":"2004","unstructured":"Lynch TJ, Bell DW, Sordella R, Gurubhagavatula S, Okimoto RA, Brannigan BW, Harris PL, Haserlat SM, Supko JG, Haluska FG, Louis DN, Christiani DC, Settleman J, Haber DA: Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 2004, 350: 2129-39. 10.1056\/NEJMoa040938","journal-title":"N Engl J Med"},{"key":"621_CR71","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1126\/science.1099314","volume":"304","author":"JG Paez","year":"2004","unstructured":"Paez JG, J\u00e4nne PA, Lee JC, Tracy S, Greulich H, Gabriel S, Herman P, Kaye FJ, Lindeman N, Boggon TJ, Naoki K, Sasaki H, Fujii Y, Eck MJ, Sellers WR, Johnson BE, Meyerson M: EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 2004, 304: 1497-500. 10.1126\/science.1099314","journal-title":"Science"},{"key":"621_CR72","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1093\/annonc\/mdh011","volume":"15","author":"G Selvaggi","year":"2004","unstructured":"Selvaggi G, Novello S, Torri V, Leonardo E, De Giuli P, Borasio P, Mossetti C, Ardissone F, Lausi P, Scagliotti GV: Epidermal growth factor receptor overexpression correlates with a poor prognosis in completely resected non-small-cell lung cancer. Ann Oncol 2004, 15: 28-32. 10.1093\/annonc\/mdh011","journal-title":"Ann Oncol"},{"key":"621_CR73","doi-asserted-by":"publisher","first-page":"e73","DOI":"10.1371\/journal.pmed.0020073","volume":"2","author":"W Pao","year":"2005","unstructured":"Pao W, Miller VA, Politi KA, Riely GJ, Somwar R, Zakowski MF, Kris MG, Varmus H: Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain. PLoS Med 2005, 2: e73. 10.1371\/journal.pmed.0020073","journal-title":"PLoS Med"},{"key":"621_CR74","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/nrm1962","volume":"7","author":"A Citri","year":"2006","unstructured":"Citri A, Yarden Y: EGF-ERBB signalling: towards the systems level. Nat Rev Mol Cell Biol 2006, 7: 505-16. 10.1038\/nrm1962","journal-title":"Nat Rev Mol Cell Biol"},{"key":"621_CR75","doi-asserted-by":"publisher","first-page":"8163","DOI":"10.1158\/0008-5472.CAN-06-0453","volume":"66","author":"KD Carey","year":"2006","unstructured":"Carey KD, Garton AJ, Romero MS, Kahler J, Thomson S, Ross S, Park F, Haley JD, Gibson N, Sliwkowski MX: Kinetic analysis of epidermal growth factor receptor somatic mutant proteins shows increased sensitivity to the epidermal growth factor receptor tyrosine kinase inhibitor, erlotinib. Cancer Res 2006, 66: 8163-8171. 10.1158\/0008-5472.CAN-06-0453","journal-title":"Cancer Res"},{"key":"621_CR76","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1042\/BJ20051962","volume":"397","author":"K Sakai","year":"2006","unstructured":"Sakai K, Yokote H, Murakami-Murofushi K, Tamura T, Saijo N, Nishio K: In-frame deletion in the EGF receptor alters kinase inhibition by gefitinib. Biochem J 2006, 397: 537-43. 10.1042\/BJ20051962","journal-title":"Biochem J"},{"key":"621_CR77","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1158\/0008-5472.CAN-06-4293","volume":"67","author":"R Mulloy","year":"2007","unstructured":"Mulloy R, Ferrand A, Kim Y, Sordella R, Bell DW, Haber DA, Anderson KS, Settleman J: Epidermal growth factor receptor mutants from human lung cancers exhibit enhanced catalytic activity and increased sensitivity to gefitinib. Cancer Res 2007, 67: 2325-30. 10.1158\/0008-5472.CAN-06-4293","journal-title":"Cancer Res"},{"key":"621_CR78","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1073\/pnas.0709662105","volume":"105","author":"CH Yun","year":"2008","unstructured":"Yun CH, Mengwasser KE, Toms AV, Woo MS, Greulich H, Wong KK, Meyerson M, Eck MJ: The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP. Proc Natl Acad Sci USA 2008, 105: 2070-5. 10.1073\/pnas.0709662105","journal-title":"Proc Natl Acad Sci USA"},{"key":"621_CR79","doi-asserted-by":"publisher","first-page":"14112","DOI":"10.1073\/pnas.0806158105","volume":"105","author":"U Guha","year":"2008","unstructured":"Guha U, Chaerkady R, Marimuthu A, Patterson AS, Kashyap MK, Harsha HC, Sato M, Bader JS, Lash AE, Minna JD, Pandey A, Varmus HE: Comparisons of tyrosine phosphorylated proteins in cells expressing lung cancer-specific alleles of EGFR and KRAS. Proc Natl Acad Sci USA 2008, 105: 14112-7. 10.1073\/pnas.0806158105","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["BMC Systems Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-0509-5-29.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T13:14:35Z","timestamp":1630502075000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcsystbiol.biomedcentral.com\/articles\/10.1186\/1752-0509-5-29"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,18]]},"references-count":79,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["621"],"URL":"https:\/\/doi.org\/10.1186\/1752-0509-5-29","relation":{},"ISSN":["1752-0509"],"issn-type":[{"value":"1752-0509","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,18]]},"assertion":[{"value":"8 February 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"29"}}